Maravai LifeSciences Holdings ROA 2019-2026 | MRVI
Current and historical return on assets (ROA) values for Maravai LifeSciences Holdings (MRVI) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Maravai LifeSciences Holdings ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2026-03-31 | $-0.11B | $0.81B | -13.13% |
| 2025-12-31 | $-0.13B | $0.87B | -15.19% |
| 2025-09-30 | $-0.12B | $0.93B | -13.14% |
| 2025-06-30 | $-0.19B | $1.04B | -18.63% |
| 2025-03-31 | $-0.16B | $1.17B | -13.89% |
| 2024-12-31 | $-0.15B | $1.30B | -11.20% |
| 2024-09-30 | $-0.23B | $1.42B | -15.91% |
| 2024-06-30 | $-0.13B | $1.66B | -8.06% |
| 2024-03-31 | $-0.13B | $1.87B | -7.02% |
| 2023-12-31 | $-0.12B | $2.08B | -5.71% |
| 2023-09-30 | $0.03B | $2.28B | 1.10% |
| 2023-06-30 | $0.08B | $2.28B | 3.29% |
| 2023-03-31 | $0.15B | $2.26B | 6.79% |
| 2022-12-31 | $0.22B | $2.19B | 10.06% |
| 2022-09-30 | $0.24B | $2.10B | 11.36% |
| 2022-06-30 | $0.25B | $2.01B | 12.36% |
| 2022-03-31 | $0.23B | $1.86B | 12.12% |
| 2021-12-31 | $0.18B | $1.69B | 10.76% |
| 2021-09-30 | $0.15B | $1.53B | 9.87% |
| 2021-06-30 | $0.14B | $1.06B | 12.88% |
| 2021-03-31 | $0.09B | $0.66B | 13.42% |
| 2020-12-31 | $0.09B | $0.32B | 27.69% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.356B | $0.186B |
| Maravai LifeSciences Holdings Inc. is a life sciences company providing products for the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company offer products and services in the fields of nucleic acid synthesis, bioprocess impurity detection and analysis, protein labeling and detection to biopharmaceutical, vaccine, diagnostics and cell and gene therapy companies. Maravai LifeSciences Holdings Inc. is based in SAN DIEGO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $152.983B | 16.86 |
| Stryker (SYK) | United States | $116.806B | 22.75 |
| Medtronic (MDT) | Ireland | $101.469B | 14.34 |
| EssilorLuxottica (ESLOY) | France | $89.470B | 0.00 |
| Boston Scientific (BSX) | United States | $65.890B | 14.30 |
| Medline (MDLN) | United States | $45.598B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.521B | 0.00 |
| Agilent Technologies (A) | United States | $35.725B | 21.77 |
| GE HealthCare Technologies (GEHC) | United States | $27.585B | 13.30 |
| ResMed (RMD) | United States | $27.336B | 17.50 |
| Koninklijke Philips (PHG) | Netherlands | $26.518B | 15.42 |
| Terumo (TRUMY) | Japan | $20.489B | 22.77 |
| Zimmer Biomet Holdings (ZBH) | United States | $16.849B | 10.27 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.494B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.510B | 0.00 |
| Baxter (BAX) | United States | $10.154B | 9.45 |
| Insulet (PODD) | United States | $9.626B | 25.83 |
| Demant (WILYY) | Denmark | $8.153B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.523B | 30.33 |
| Lantheus Holdings (LNTH) | United States | $6.914B | 21.33 |
| BillionToOne (BLLN) | United States | $4.633B | 0.00 |
| Envista Holdings (NVST) | United States | $4.151B | 19.33 |
| DiaSorin S.p.A (DSRLF) | Italy | $4.062B | 0.00 |
| ICU Medical (ICUI) | United States | $3.403B | 21.44 |
| Haemonetics (HAE) | United States | $3.296B | 14.59 |
| Curaleaf Holdings (CURLD) | Canada | $2.248B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.154B | 10.35 |
| GN Store Nord (GNNDY) | Denmark | $2.053B | 97.19 |
| LeMaitre Vascular (LMAT) | United States | $2.025B | 34.35 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $1.951B | 0.00 |
| Neogen (NEOG) | United States | $1.942B | 42.48 |
| Capricor Therapeutics (CAPR) | United States | $1.699B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.584B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.522B | 16.27 |
| AtriCure (ATRC) | United States | $1.440B | 948.00 |
| Perrigo (PRGO) | Ireland | $1.328B | 3.74 |
| AdaptHealth (AHCO) | United States | $1.313B | 33.31 |
| Phibro Animal Health (PAHC) | United States | $1.260B | 10.60 |
| BioLife Solutions (BLFS) | United States | $1.217B | 207.50 |
| Kestra Medical Technologies (KMTS) | United States | $1.210B | 0.00 |
| Lumexa Imaging Holdings (LMRI) | United States | $0.912B | 0.00 |
| QuidelOrtho (QDEL) | United States | $0.844B | 9.23 |
| InMode (INMD) | Israel | $0.759B | 9.57 |
| Omeros (OMER) | United States | $0.748B | 4.74 |
| CeriBell (CBLL) | United States | $0.690B | 0.00 |
| Brainsway (BWAY) | Israel | $0.577B | 41.09 |
| Tilray Brands (TLRY) | Canada | $0.535B | 0.00 |
| Cerus (CERS) | United States | $0.521B | 0.00 |
| Valneva SE (VALN) | France | $0.508B | 0.00 |
| Vireo Growth (VREOD) | United States | $0.472B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.438B | 10.95 |
| Evolus (EOLS) | United States | $0.434B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.417B | 29.38 |
| Verano Holdings (VRNO) | United States | $0.415B | 0.00 |
| Verano Holdings (VRNOD) | United States | $0.392B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.387B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.387B | 0.00 |
| SNDL (SNDL) | Canada | $0.360B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.359B | 17.46 |
| MacroGenics (MGNX) | United States | $0.291B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.286B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.258B | 0.00 |
| Accendra Health (ACH) | United States | $0.245B | 4.71 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Village Farms (VFF) | Canada | $0.214B | 8.50 |
| Utah Medical Products (UTMD) | United States | $0.211B | 19.57 |
| High Tide (HITI) | Canada | $0.201B | 57.25 |
| Sanara MedTech (SMTI) | United States | $0.199B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.198B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.176B | 47.83 |
| Apyx Medical (APYX) | United States | $0.168B | 0.00 |
| Quanterix (QTRX) | United States | $0.164B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.164B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Organigram Global (OGI) | Canada | $0.135B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.133B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| Exagen (XGN) | United States | $0.107B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.102B | 13.71 |
| Jushi Holdings (JUSHF) | United States | $0.092B | 0.00 |
| ImmuCell (ICCC) | United States | $0.088B | 0.00 |
| Biote (BTMD) | United States | $0.085B | 5.11 |
| Hongchang (HCIL) | China | $0.081B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.077B | 27.30 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| InterCure (INCR) | Israel | $0.060B | 0.00 |
| Veru (VERU) | United States | $0.048B | 0.00 |
| Nephros (NEPH) | United States | $0.035B | 46.57 |
| United-Guardian (UG) | United States | $0.032B | 13.46 |
| Rockwell Medical (RMTI) | United States | $0.026B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.026B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.021B | 0.00 |
| Modular Medical (MODD) | United States | $0.020B | 0.00 |
| Jin Medical (ZJYL) | China | $0.019B | 0.00 |
| Bonk (BNKK) | United States | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Akanda (AKAN) | Canada | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| INLIF (INLF) | China | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |